Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

12 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Through the looking glass: understanding non-inferiority.
Schumi J, Wittes JT. Schumi J, et al. Trials. 2011 May 3;12:106. doi: 10.1186/1745-6215-12-106. Trials. 2011. PMID: 21539749 Free PMC article. Review.
Testing for associations with missing high-dimensional categorical covariates.
Schumi J, DiRienzo AG, DeGruttola V. Schumi J, et al. Int J Biostat. 2008 Sep 29;4(1):Article 18. doi: 10.2202/1557-4679.1102. Int J Biostat. 2008. PMID: 20231909 Free PMC article.
Assessment of the Cardiovascular Risk of Olmesartan Medoxomil-Based Treatment: Meta-Analysis of Individual Patient Data.
Wang AC, Stellmacher U, Schumi J, Tu N, Reimitz PE. Wang AC, et al. Among authors: schumi j. Am J Cardiovasc Drugs. 2016 Dec;16(6):427-437. doi: 10.1007/s40256-016-0182-3. Am J Cardiovasc Drugs. 2016. PMID: 27565974
Effects of succinobucol (AGI-1067) after an acute coronary syndrome: a randomised, double-blind, placebo-controlled trial.
Tardif JC, McMurray JJ, Klug E, Small R, Schumi J, Choi J, Cooper J, Scott R, Lewis EF, L'Allier PL, Pfeffer MA; Aggressive Reduction of Inflammation Stops Events (ARISE) Trial Investigators. Tardif JC, et al. Among authors: schumi j. Lancet. 2008 May 24;371(9626):1761-8. doi: 10.1016/S0140-6736(08)60763-1. Lancet. 2008. PMID: 18502300 Clinical Trial.
[No authors listed] [No authors listed] PMID: 30983382
Development Review of the BACE1 Inhibitor Lanabecestat (AZD3293/LY3314814).
Sims JR, Selzler KJ, Downing AM, Willis BA, Aluise CD, Zimmer J, Bragg S, Andersen S, Ayan-Oshodi M, Liffick E, Eads J, Wessels AM, Monk S, Schumi J, Mullen J. Sims JR, et al. Among authors: schumi j. J Prev Alzheimers Dis. 2017;4(4):247-254. doi: 10.14283/jpad.2017.38. J Prev Alzheimers Dis. 2017. PMID: 29181490 Review.
Disease Modification in Alzheimer's Disease: Current Thinking.
Liu-Seifert H, Schumi J, Miao X, Tian Y, Rabbia M, Andersen SW, Wilson S, Li W, Entsuah R. Liu-Seifert H, et al. Among authors: schumi j. Ther Innov Regul Sci. 2020 Mar;54(2):396-403. doi: 10.1007/s43441-019-00068-4. Epub 2020 Jan 6. Ther Innov Regul Sci. 2020. PMID: 32072596 Review.
Efficacy and Safety of Lanabecestat for Treatment of Early and Mild Alzheimer Disease: The AMARANTH and DAYBREAK-ALZ Randomized Clinical Trials.
Wessels AM, Tariot PN, Zimmer JA, Selzler KJ, Bragg SM, Andersen SW, Landry J, Krull JH, Downing AM, Willis BA, Shcherbinin S, Mullen J, Barker P, Schumi J, Shering C, Matthews BR, Stern RA, Vellas B, Cohen S, MacSweeney E, Boada M, Sims JR. Wessels AM, et al. Among authors: schumi j. JAMA Neurol. 2019 Nov 25;77(2):199-209. doi: 10.1001/jamaneurol.2019.3988. Online ahead of print. JAMA Neurol. 2019. PMID: 31764959 Free PMC article.
Rivaroxaban with or without Aspirin in Stable Cardiovascular Disease.
Eikelboom JW, Connolly SJ, Bosch J, Dagenais GR, Hart RG, Shestakovska O, Diaz R, Alings M, Lonn EM, Anand SS, Widimsky P, Hori M, Avezum A, Piegas LS, Branch KRH, Probstfield J, Bhatt DL, Zhu J, Liang Y, Maggioni AP, Lopez-Jaramillo P, O'Donnell M, Kakkar AK, Fox KAA, Parkhomenko AN, Ertl G, Störk S, Keltai M, Ryden L, Pogosova N, Dans AL, Lanas F, Commerford PJ, Torp-Pedersen C, Guzik TJ, Verhamme PB, Vinereanu D, Kim JH, Tonkin AM, Lewis BS, Felix C, Yusoff K, Steg PG, Metsarinne KP, Cook Bruns N, Misselwitz F, Chen E, Leong D, Yusuf S; COMPASS Investigators. Eikelboom JW, et al. N Engl J Med. 2017 Oct 5;377(14):1319-1330. doi: 10.1056/NEJMoa1709118. Epub 2017 Aug 27. N Engl J Med. 2017. PMID: 28844192 Free article. Clinical Trial.
12 results
Jump to page
Feedback